Literature DB >> 11524480

Miller Fisher syndrome and Haemophilus influenzae infection.

M Koga1, N Yuki, T Tai, K Hirata.   

Abstract

OBJECTIVE: To examine the association between Miller Fisher syndrome (MFS) and antecedent Haemophilus influenzae infection.
BACKGROUND: Little is known about agents in prior respiratory tract infection of MFS, whereas antecedent upper respiratory symptoms are frequent. H. influenzae is a major pathogen that can cause human respiratory tract infection.
METHODS: The authors used ELISA to detect serum antibody against the bacterium in 70 consecutive patients with MFS and 110 with Guillain-Barré syndrome (GBS).
RESULTS: Serum anti-H. influenzae IgG and IgM antibody activities were significantly higher in the MFS group than in age- and sex-matched patients with other neurologic diseases (n = 62) and normal control subjects (n = 82). The GBS group showed no significant increase in any class of antibody activities compared with control groups. Serologic evidence of recent infection was found in five (7%) of the patients with MFS and two (2%) of 110 patients with GBS, all of whom had a history of antecedent respiratory tract infection. They frequently showed ophthalmoplegia, but other neurologic features were not remarkable. Serum anti-GQ1b IgG antibody that had cross-reactivity with GT1a ganglioside was detected in six of these seven patients. Thin-layer chromatography with immunostaining showed that serum IgG from H. influenzae-seropositive patients with high anti-GQ1b and anti-GT1a IgG antibody titers bound to the lipopolysaccharide fraction extracted from the type b H. influenzae serostrain. These bands were also stained by anti-GT1a monoclonal antibody (GMR11), indicating that the lipopolysaccharide bears the GT1a epitope.
CONCLUSIONS: These findings point to H. influenzae being an agent associated with MFS. Epitopic overlap between H. influenzae and human nerve tissue may be involved in the development of MFS much as GBS is associated with Campylobacter jejuni enteritis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11524480     DOI: 10.1212/wnl.57.4.686

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  15 in total

1.  Immunoglobulin KM genes in Guillain-Barré syndrome.

Authors:  Janardan P Pandey; Christian A Vedeler
Journal:  Neurogenetics       Date:  2003-02-11       Impact factor: 2.660

2.  Fisher syndrome.

Authors:  Masahiro Mori; Satoshi Kuwabara
Journal:  Curr Treat Options Neurol       Date:  2011-02       Impact factor: 3.598

Review 3.  Therapy of immune neuropathies with intravenous immunoglobulins.

Authors:  Ralf Gold; Bernd C Kieseier
Journal:  J Neurol       Date:  2006-09       Impact factor: 4.849

4.  Miller Fisher syndrome.

Authors:  Suresh Kumar Gupta; Kunal Kishor Jha; Mhd Diaa Chalati; Losan Tareq Alashi
Journal:  BMJ Case Rep       Date:  2016-10-13

5.  Miller-Fisher syndrome mimicking intracranial hypertension following head trauma.

Authors:  S Pulitanò; L Viola; O Genovese; A Chiaretti; M Piastra; P Mariotti; F Di Rocco; G Polidori; C Di Rocco
Journal:  Childs Nerv Syst       Date:  2005-04-13       Impact factor: 1.475

6.  Prospective study on anti-ganglioside antibodies in childhood Guillain-Barré syndrome.

Authors:  J Schessl; M Koga; K Funakoshi; J Kirschner; W Muellges; A Weishaupt; R Gold; R Korinthenberg
Journal:  Arch Dis Child       Date:  2006-08-18       Impact factor: 3.791

7.  Anti-GT1a IgG in Guillain-Barré syndrome.

Authors:  M Koga; H Yoshino; M Morimatsu; N Yuki
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-06       Impact factor: 10.154

Review 8.  The role of infections in autoimmune disease.

Authors:  A M Ercolini; S D Miller
Journal:  Clin Exp Immunol       Date:  2009-01       Impact factor: 4.330

Review 9.  Guillain-Barré syndrome, transverse myelitis and infectious diseases.

Authors:  Yhojan Rodríguez; Manuel Rojas; Yovana Pacheco; Yeny Acosta-Ampudia; Carolina Ramírez-Santana; Diana M Monsalve; M Eric Gershwin; Juan-Manuel Anaya
Journal:  Cell Mol Immunol       Date:  2018-01-29       Impact factor: 11.530

Review 10.  Guillain-Barré syndrome and anti-ganglioside antibodies: a clinician-scientist's journey.

Authors:  Nobuhiro Yuki
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2012       Impact factor: 3.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.